- Switching to a preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% reduced intraocular pressure over a 24-hour period and improved ocular surface disease signs and symptoms.
- The study included 38 patients with open-angle glaucoma or ocular hypertension.
- Assessment tools such as DEQ-5 and NEI-VFQ25 were used to evaluate OSD symptoms and quality of life.
- Corneal fluorescein staining and hyperemia showed improvement in a significant percentage of patients.
- The study suggested potential recovery of epithelial homeostasis with the use of the preservative-free fixed combination.
Preservative-Free Fixed Combination Decreases IOP in Patients Who Switched From BAK-Latanoprost
Conexiant
March 13, 2025
